Compare Medtronic PLC (MDT) vs NRG Energy Inc (NRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs NRG Energy Inc — how do they compare? Medtronic PLC trades at $82.65 (market cap $106.61B), while NRG Energy Inc trades at $132.21 (market cap $27.55B). The key difference: Medtronic PLC is far larger — about 3.9× NRG Energy Inc's market cap, and Medtronic PLC pays the higher dividend (3.46%). Which is the better fit depends on your goals.
| MDT | NRG | |
|---|---|---|
Market Cap | $106.61B | $27.55B |
Sector | Health | Utilities |
52-Week High | $105.35 | $184.03 |
52-Week Low | $73.75 | $120.65 |
Enterprise Value | $125.36B | $51.38B |
Dividend Yield | 3.46% | 1.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
NRG Energy trades at $131.02, up 1.48% with a bearish technical signal despite recent earnings beats. The stock shows mixed fundamentals with strong revenue growth to $30.71B but thin net margins of 0.74%. Analyst consensus remains bullish with a $196.33 price target, representing 50% upside potential from current levels. Recent news highlights expanding generation capacity and data center deals as growth catalysts.
The outlook balances strong analyst support against elevated valuation multiples and technical weakness. Key opportunities include power demand growth and strategic positioning, while risks involve margin pressure and debt levels exceeding 56% of assets. The upcoming Q2 2026 earnings report on August 4 will be critical for confirming growth trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About NRG Energy Inc
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →
